Multiple myeloma dr harpreet singh bhatia dmch, ludhiana,punjab 2. Multiple myeloma symptoms, diagnosis and treatment bmj. How is hypercalcemia treated in patients with multiple. Download the pdf esmomagnitude of clinical benefit scale clinical practice guidelines patient. Multiple myeloma and common symptoms about 10% to 20% of patients with newly diagnosed myeloma will not have any symptoms. Progress in our understanding of multiple myeloma and its treatment has resulted in a more tailored approach to patient management, with. Richardson1 abstract panobinostat is a potent oral deacetylase inhibitor that alters gene expression through epigenetic mechanisms and inhibits protein degradation. The following are a few of the topics that the imwg covers. Management of relapsed and refractory multiple myeloma. At the washington dc vamc dcvamc we started early on bisphosphonates and thalidomide without much benefit, but perhaps we were treating the wrong disease. Personal history of a monoclonal gammopathy of undetermined significance mgus. Malignanat b cell lymphoproliferative disorder of the marrow with plasma cell predominating. Abstract multiple myeloma accounts for approximately 10% of. Algorithm for the initial evaluation and management of a patient with multiple myeloma.
Nov 16, 2017 despite enormous advances, management of multiple myeloma mm remains challenging. The patient handbook focuses on the questions and decisions that a newly diagnosed patient faces. Pdf multiple myeloma mm is a plasma cell dyscrasia that accounts for 10% of haematological malignancies. Updates to the guidelines for the diagnosis and management of multiple myeloma. Pdf on nov 29, 2005, alastair smith and others published guidelines on the diagnosis and management of multiple myeloma 2005 find. Our aim was to investigate and critically examine the effects of various treatment modalities on outcome in patients with multiple myeloma and address 22 specific clinical questions in the management of this disease. Multiple myeloma information and resources myeloma explained. As a result of our analysis we identified two therapeutic. Apr 09, 2020 treatment for myeloma induced hypercalcemia is the same as that for other malignancyassociated hypercalcemia. This means they treat the tumor without affecting the rest of the body. Objective multiple myeloma can pose a diagnostic challenge and this article highlights issues in diagnosis and provides an overview of management. An approach to the diagnosis and management of multiple myeloma. International myeloma working group recommendations for the diagnosis and management of myeloma related renal impairment. International myeloma working group recommendations for the diagnosis and management of myelomarelated renal impairment.
The myeloma crowd provides patients with simplified myeloma education, funding for key myeloma research and data solutions to solve patient and research problems. In recent years, the therapeutic options to treat mm have rapidly expanded leading to. First described in 1848, mm is characterized by a proliferation of malignant plasma cells and a subsequent overabundance of monoclonal paraprotein m protein. The advent of new, more effective, and less toxic therapies has revolutionized the management of multiple myeloma in the past decade. Multiple myeloma mm is a malignancy of plasma cells which represents about 2% of all new cancer cases in the united kingdom. Improvement of access to quality diagnostics and novel therapeutics is crucial to the improvement of survival outcomes of patients. Multiple myeloma resources and tools myeloma explained. Multiple myeloma can pose a diagnostic challenge and this article highlights issues in diagnosis and provides an overview of management. Dec 11, 2019 management of multiple myeloma through an interprofessional approach.
Multiple myeloma diagnosis and treatment mayo clinic. Background multiple myeloma is characterised by the proliferation of malignant plasma cells within the bone marrow, which produce an abnormal monoclonal paraprotein and evidence of end organ damage. This website provides you with helpful information and resources to find out more about multiple myeloma. An area that is becoming very important is identifying and separating smoldering multiple myeloma smm from multiple myeloma mm and determining when to start treatment.
This educational activity is supported by an educational grant from sanofi genzyme. These treatments are more likely to be useful for earlier. The nccn guidelines panel for cervical cancer screening endorses the following guidelines for the prevention and early detection of cervical cancer. These current guidelines represent a major revision. Panobinostat for the treatment of multiple myeloma jacob p. Treatment of multiple myeloma blood american society. The management of multiple myeloma in asia can be challenging. International myeloma working group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Multiple myeloma, the most common bone malignancy, is occurring with increasing frequency in older persons. Multiple myeloma mm is a fatal, malignant neoplasm that originates in the plasma cells of bone marrow. Multiple myeloma can present with a wide constellation of symptoms including hypercalcaemia, anaemia, renal impairment andor bony pain. It is almost invariably preceded by premalignant stages of monoclonal gammopathy of undetermined significance mgus and smoldering mm smm, although not all cases of mgus will eventually progress to mm.
In this article, we discuss multiple myeloma in terms of pathogenesis and chromosomal abnor. Despite enormous advances, management of multiple myeloma mm remains challenging. The mission of the multiple myeloma research foundation is to accelerate next generation multiple myeloma treatments to extend patients lives in pursuit of a cure. Utilization of treatment combinations and sequencing of regimens provided by american academy of cme, inc. Imwg publishes recommendations for the diagnosis and management of myelomarelated renal impairment. His research interests are in multiple myeloma and the bone marrow microenvironment as a potential therapeutic target.
Multiple myeloma represents 2% of all new cancer diagnoses in the united. Role of 18ffdg petct in the diagnosis and management of multiple myeloma and other plasma cell disorders. Pdf guidelines on the diagnosis and management of multiple. May 18, 2018 kyle ra, durie bg, rajkumar sv, et al. Genomic instability, a hallmark of multiple myeloma, is already present at the stage of monoclonal gammopathy of undetermined significance mgus, 1012 but it is not clear whether mgus represents a prerequisite precursor stage for all cases of myeloma. Management of multiple myeloma through an interprofessional approach. In this article, we discuss multiple myeloma in terms of pathogenesis and chromosomal abnormalities, staging, treatment, radiographic evalu. Learn more about the symptoms, causes, diagnosis, risk factors, and treatment of multiple myeloma. American cancer society, american society for colposcopy and cervical pathology, and american society for clinical pathology screening guidelines for the prevention and early detection of cervical cancer. Nooka1 abstract the prognosis of patients with multiple myeloma has signi. Dec 29, 2015 the prognosis for patients multiple myeloma mm has improved substantially over the past decade with the development of new, more effective chemotherapeutic agents and regimens that possess a. Monoclonal gammopathy of undetermined significance mgus and smoldering asymptomatic multiple myeloma. Multiple myeloma is a type of cancer that targets the plasma cells in bone marrow. This guideline covers the diagnosing and managing of myeloma including smouldering myeloma and primary plasma cell leukaemia in people aged 16 and over.
Diagnosing multiple myeloma in primary care clinician. Us national library of medicine database pubmed, medical literature analysis and retrieval system online medline, excerpta medica database embase, cumulative index to nursing and allied health. Physiotherapy management guidelines for patients with multiple myeloma will be developed based on the results of a systematic search of the following databases. Multiple factors impact the decision to treat or which regimen to use at mm relapseprogression. Multiple myeloma mm is a debilitating malignancy that is part of a spectrum of diseases ranging from monoclonal gammopathy of unknown significance mgus to plasma cell leukemia. The international myeloma working groups imwg summaries focus on guidelines and statements about certain aspects of multiple myeloma. Overview this guideline covers the diagnosing and managing of myeloma including smouldering myeloma and primary plasma cell leukaemia in people aged 16 and over. Multiple myeloma is the second most common type of blood cancer after leukemia. The survival time of patients with plasmocytic myeloma. Aug 16, 2018 multiple myeloma accounts for 1% of all cancers and approximately 10% of all hematologic malignancies. Myeloma is called multiple because it frequently involves multiple areas in the body. Treatment for myelomainduced hypercalcemia is the same as that for other malignancyassociated hypercalcemia.
Treatment options for tripleclass refractory multiple myeloma. Myeloma management and treatment guidelines summaries. It aims to improve care for people with myeloma by promoting the most effective tests and treatments for myeloma and its complications. The serum free light chain testing quantifies levels of free. Multiple myeloma is a disease in which a neoplastic proliferation of plasma cells produces a monoclonal immunoglobulin. The guideline has been split into two documents, focussing on the diagnosis and management of multiple myeloma and supportive care in multiple myeloma 2011 snowden et al 2011. In 2015, an estimated 28,850 new cases of multiple myeloma were. A genetic mutation in the plasma cells creates myeloma primary care providers play a significant role in the diagnosis of multiple myeloma, a detrimental disease of insidious onset. The imwgs research on multiple myeloma studies its causes, how to stage the disease, and how to achieve remission. It aims to improve care for people with myeloma by promoting the most effective tests. A change in the bone marrow or a mutation in a plasma cells dna.
Drug therapy for multiple myeloma stem cell transplant for multiple myeloma supportive treatments for patients with multiple myeloma common treatment approaches depending on the stage of the cancer, whether or not you are a candidate for a stem cell transplant, and other factors, different types of treatment may be combined at the same time or. Multiple myeloma mm is a disease that is primarily treated by hematologists. Jun 12, 2019 black people are about twice as likely to develop multiple myeloma as are white people. Healthcare resources need to be optimised to achieve this goal. Imwg consensus perspectives risk factors for progression and guidelines for monitoring and management. Guidelines for the diagnosis and management of multiple. Multiple myeloma mm belongs to the group of plasma cell neoplasms table 1. Multiple myeloma accounts for 1% of all cancers and approximately 10% of all hematologic malignancies. The prognosis for patients multiple myeloma mm has improved substantially over the past decade with the development of new, more effective chemotherapeutic agents and. Plasma cells come from b lymphocytes, and produce antibodies immunoglobulins. Mr imaging and petct in diagnosis and management of multiple. If a brother, sister or parent has multiple myeloma, you have an increased risk of the disease. In 2006 guidelines for the diagnosis and management of multiple myeloma were published smith et al, 2006. Mr imaging and petct in diagnosis and management of.
Pdf an approach to the diagnosis and management of multiple. It will help you learn medical terms and concepts you may not have encountered before. Patients may present with bone pain or with symptoms that are often nonspecific, such as nausea. Multiple myeloma represents 2% of all new cancer diagnoses in the united kingdom and accounts for 2% of all cancer deaths. Treatment of multiple myeloma blood american society of. Despite the availability of new treatments, most patients with multiple myeloma will become refractory to the therapies that currently comprise the hematologic standard of care for the malignancy, including proteasome inhibitors, immunomodulatory agents, and. Two and 3drug treatment regimens and autologous stem cell transplants provide opportunities for longer term disease remission, though most patients will still develop relapsed multiple myeloma. Mm is most frequently diagnosed in people aged 65 to. A overall survival os in patients with mult iple myeloma stratified by revised international staging system riss algorithm.
37 191 527 1225 954 1297 403 323 1194 715 394 1474 46 701 1071 1564 1073 1184 1536 174 76 258 388 1104 128 832 541 1198 1381 1371 1065 65 401 1218 401 915 106 369 873